Oramed Pharmaceuticals Inc

ORMP · Moat type: REGULIERUNG

MoatScore

1/10

Fair Value

n/a

Margin of Safety

n/a

Rating

MEIDEN

Oramed Pharmaceuticals is a clinical biotechnology company that focuses on developing oral dosage forms for medications that typically can only be administered by injection, particularly oral insulin and oral exenatide for diabetes patients.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.